Search Results

CoreBiome, a microbiome analysis and discovery company, was awarded a $220,000 grant to accelerate the commercialization of technology licensed from the University of Minnesota.

CoreBiom announced that Rob Knight, Professor and Director of the Center for Microbiome Innovation at the University of California San Diego, has joined its scientific advisory board.

CoreBiome announced new $99 shotgun metagenomic and strain sequencing tests.

CoreBiome announced the appointment of Dr. Daniel Pomp, Ph.D., a world leader in agricultural and biomedical genomics, to its Board of Directors.

Rebiotix, announced today its successful first phase of collaboration with CoreBiome to measure the ability of RBX2660 and RBX7455 to rehabilitate the human microbiome impacted by recurrent Clostridium difficile infection.

According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined.

OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench

Metagenomics is defined as the extensive study of various types of genetic material recovered directly from environmental samples, which is further used for many purposes such as identification of a microbial species, classification of microorganisms, and understanding their importance on the planet dating back to their origin.

OraSure Technologies, Inc., announced that its 2020 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT on Tuesday, May 19, 2020.